Dow Up 1.37% Nasdaq Up 1.43%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.55 Up 0.10(3.88%) 10:30AM EDT - Nasdaq Real Time Price
Prev Close:2.45
Open:2.48
Bid:2.52 x 1600
Ask:2.53 x 900
1y Target Est:7.00
Beta:3.36
Next Earnings Date:N/A
Day's Range:2.45 - 2.55
52wk Range:1.55 - 6.87
Volume:157,194
Avg Vol (3m):804,306
Market Cap:213.19M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IDRA

Comparison

Symbol% ChgMkt Cap
IDRAUp 3.88%213.19M
DVAXUp 1.36%391.69M
PFEUp 1.86%182.78B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,946.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback